Helmholtz-Zentrum Für Infektionsforschung Gmbh;Medizinische Hochschule Hannover
发明人:
Bettina Hinkelmann,Florenz Sasse,Heinrich Steinmetz,Irina Nickeleit,Nisar Malek,Ronald Frank
申请号:
BRPI0808035
公开号:
BRPI0808035A2
申请日:
2008.02.27
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
The present invention relates to the use of particular macrocycles that are inhibitors of the proteasomic degradation of p27 for the treatment of cancer, as well as the derivatisation of said macrocycles. As an example argyrin A or argyrin F may be used.